ZCMDHealthcare · Health Information ServicesZCMD Stock Forecast: Zhongchao, Inc. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 22 of 100 as at 19 Sept 2026 — in the weakest quartile.
ZCMD stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Zhongchao, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Accruals (97): Reported profit is backed by cash, and the company is not expanding recklessly.
Value (5): The shares cost a lot relative to the profits and assets behind them.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
ZCMD stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on ZCMD, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ZCMD appears on the weeks it earns a place.
ZCMD vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 18 Sept 2026, Zhongchao, Inc. returned −99.7% against +16.3% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
ZCMD analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Zhongchao, Inc. (ZCMD) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- 0.6×
- Price / book
- 0.1×
- EV / EBITDA
- 1.7×
Cheaper than 79% of US stocks
Cheaper than 90% of US stocks
Cheaper than 57% of US stocks
- Revenue growth (YoY)
- −23.2%
- Earnings growth (YoY)
- —
- Gross margin
- —
- Operating margin
- −92.0%
- Net margin
- −55.5%
Higher than 11% of US stocks
Higher than 14% of US stocks
Higher than 10% of US stocks
- Return on equity
- −24.9%
- Return on assets
- −15.5%
- Dividend yield
- —
Higher than 29% of US stocks
Higher than 22% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
Zhongchao, Inc. (ZCMD) statistics: revenue, profit & scale
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Zhongchao, Inc. has a market value of $7.0M and an enterprise value of −$9.9M.
Zhongchao, Inc. employs 33 people.
Data provided by Twelve Data
ZCMD vs competitors
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Zhongchao, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Frequently asked questions about ZCMD stock
How does Ticker Nerd's model rank ZCMD?
As at 19 Sept 2026, Zhongchao, Inc. ranks 22 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (97 of 100).
What is the ZCMD stock forecast for 2030?
No analyst covering Zhongchao, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ZCMD are extrapolating price history, which says nothing about the business.
How has ZCMD stock performed over the past year?
Zhongchao, Inc. returned -99.7% over the 12 months to 18 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Zhongchao, Inc. do?
Zhongchao Inc. Class A Ordinary Shares represent ownership in Zhongchao Inc., a Cayman Islands-based platform company focused on healthcare internet services in China.
About Zhongchao, Inc.
Zhongchao Inc. Class A Ordinary Shares represent ownership in Zhongchao Inc., a Cayman Islands-based platform company focused on healthcare internet services in China. Zhongchao provides healthcare information, education, and training services to patients and healthcare professionals through its MDMOOC brand, with an emphasis on support for cancer and other major diseases. The company also operates in related healthcare service areas, including sales of patented drugs, giving it exposure to both digital health services and healthcare commerce. Its business is centered on delivering online medical learning, disease education, and practical service tools that connect medical resources with end users in the Chinese healthcare market. Zhongchao Inc. Class A Ordinary Shares are used by investors to access the company’s operating results and market position within the healthcare information services segment.
CEO Mr. Weiguang Yang · 33 employees · China · https://www.izcmd.com